Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|February 5, 2017
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I studyJian Ming Xu, Yan Wang, Yu Ling Chen, et al.Journal of Medicinal Chemistry|April 30, 2019
Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual InhibitorsHong Jia, Guangxiu Dai, Weiguo Su, et al.Journal of Medicinal Chemistry|November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptorJoe A Tran, Wanlong Jiang, Fabio C Tucci, et al.Cancer Biology & Therapy|December 9, 2014
Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapyQiaoling Sun, Jinghong Zhou, Zheng Zhang, et al.Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationshipsDeborah H Slee, Manisha Moorjani, Xiaohu Zhang, et al.Pageof 4